Storys zum Thema Medizinische Forschung

Helmholtz Zentrum München

Inceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies

ARTTIC Innovation GmbH

Last Call for canSERV Third Open Call Funding

Helmholtz Zentrum München

Extreme Rainfall Poses Health Risks

Extreme Rainfall Poses Health Risks An international study led by Helmholtz Munich investigates the health consequences of heavy rainfall events. Researchers analyzed the relationship between precipitation patterns and mortality rates at 645 locations across 34 countries from 1980 to 2020. The key finding: Extremely heavy rainfall, which occurs approximately every five years, significantly increases the risk of death, ...

Briya

MSD in Strategic collaboration with Briya for Innovative RWE data analysis projects

Tel Aviv, Israel (ots/PRNewswire) - MSD, a leading multinational pharmaceutical company successfully completes a first-of-its-kind strategic collaboration with Briya, a medical data retrieval network. This groundbreaking partnership enabled innovative data analysis projects on three critical disease areas MSD plays a part in. Leveraging Briya's advanced data platform, ...

ARTTIC Innovation GmbH

Launch of canSERV Call for Service Provision – "Training the Next Generation of Cancer Researchers"

INSIGHTEC; Charles River Laboratories International, Inc.

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience

Wilmington, Mass., Miami and Haifa, Israel (ots/PRNewswire) - Collaboration stands to advance novel therapeutic applications across multiple neurologic conditions Charles River Laboratories International, Inc. (NYSE: CRL) and Insightec, a global healthcare company dedicated to using focused ultrasound to transform ...

Fördergesellschaft IZB mbH

2

Record financing rounds at the Munich biotech hub

ARTTIC Innovation GmbH

canSERV relaunches Open Call for Service Provision

ARTTIC Innovation GmbH

canSERV to Accelerate Your Cancer Research - 2 Calls for Service Provision Open

Briya

Renowned Public Health Expert Prof. Siegal Sadetzki Joins Briya

Tel Aviv, Israel (ots/PRNewswire) - Briya, a leading medical data retrieval network, proudly announces the appointment of Prof. Siegal Sadetzki as Chief Epidemiology Officer. With over three decades of experience in public health and epidemiology, Prof. Sadetzki brings a wealth of expertise to Briya's mission of making medical data accessible for research at scale and assisting hospitals in optimizing their data ...

Helmholtz Zentrum München

Press Release: Restless Legs Syndrome: Genetic Discoveries Advance Treatment and Risk Prediction

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) together with international collaborators have conducted the largest genetic investigation of the restless legs syndrome to date. Their findings, ...

ARTTIC Innovation GmbH

canSERV invites applications for "Revolutionising Cancer Patient Care"

ARTTIC Innovation GmbH

3

canSERV invites applications for "Revolutionising Cancer Patient Care"

Helmholtz Zentrum München

New Study: Night-time heat significantly increases the risk of stroke

ARTTIC Innovation GmbH

LAST CHANCE: canSERV Second Open Call for Cancer Research Service Provision

HUMA Therapeutics

Huma and Merck KGaA, Darmstadt, Germany Launch Innovative App to Support Bladder Cancer Patients

London (ots/PRNewswire) - Huma Therapeutics ("Huma"), a leader in global digital health innovation, together with Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the launch of their innovative bladder cancer treatment companion app in the United Kingdom. This collaboration underscores Merck KGaA, Darmstadt, Germany and Huma's ...

ARTTIC Innovation GmbH

3

canSERV Initiative: EU Consortium Launches Groundbreaking Call to Accelerate Cancer Research

Helmholtz Zentrum München

Advanced Brain Science Without Coding Expertise

Bosch Healthcare Solutions GmbH

Additional partnership in medical technology: Bosch and R-Biopharm to strengthen Vivalytic analysis platform

Darmstadt, Gerlingen, and Waiblingen, Germany (ots) - Plans to use innovative Bosch BioMEMS technology in PCR tests for multiresistant bacteria - Bosch and R-Biopharm are jointly investing 150 million euros in the development of new PCR tests and in marketing. - PCR test for multiresistant gram-negative (MRGN) ...

Helmholtz Zentrum München

Asthma in Children: Researchers Envision Novel Drug to Reduce the Risk of the Disease

Asthma in Children: Researchers Envision Novel Drug to Reduce the Risk of the Disease Scientists have reached a milestone in the research of childhood asthma. For the first time, they have clarified how a certain genetic defect in children initially leads to frequent infections and later to asthma. The study, published in the American Journal of Respiratory and ...

Bosch Healthcare Solutions GmbH

Bosch and Randox: Strategic partnership brings highly multiplexing PCR to the point of care / BioMEMS technology enables fully automated, simultaneous testing for hundreds of genetic characteristics in just a few minutes

Waiblingen (ots) - - Bosch and Randox Laboratories Ltd. enter partnership for Vivalytic analysis platform to jointly invest around 150 million euros. - First test to feature novel BioMEMS technology will be a highly multiplexing sepsis IVD grade test. Bosch has agreed on a strategic partnership with Randox ...

Helmholtz Zentrum München

Scientists Reveal Adipocyte's Metabolic Role and Identify Treatment Targets

Epitomee Medical

Epitomee® announces the filing of a novel Weight Loss Capsule for FDA clearance

Caesarea, Israel (ots/PRNewswire) - Epitomee® (TASE: EPIT) announced today that on February 27, 2024, it has submitted its Weight Loss Capsule for FDA clearance in the USA, reaching a significant milestone in the company's journey. The Epitomee® capsule offers an innovative, orally administered, drug free, and clinically proven as effective and safe solution, for ...

Phagenesis

Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management

Manchester, England (ots/PRNewswire) - Phagenesis, a pioneering UK company which has developed a revolutionary neurostimulation system to treat swallowing dysfunction, has closed a $42M Series D financing all equity investment round. The combined European and United States investment syndicate was led by EQT Life ...

Helmholtz Zentrum München

Rising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target

ARTTIC Innovation GmbH

iMEDCAP: EU-Projekt leistet Pionierarbeit bei der Rettung verwundeter Soldaten

Helmholtz Zentrum München

Therapeutic Vaccine for Chronic Hepatitis B Enters Clinical Trial

Helmholtz Zentrum München

What Our Genetic Information Tells Us About Type 2 Diabetes Risk and Complications

ARTTIC Innovation GmbH

2

OPTIMA cancer project announces the Region Uppsala as new partner

Epitomee Medical

Epitomee® Announces Successful Completion of Pivotal Clinical Trial for Innovative Weight Loss Capsule

Caesarea, Israel (ots/PRNewswire) - Epitomee® announces the successful completion of the RESET pivotal clinical trial, for its weight loss capsule. The randomized placebo controlled, double blind trial, investigated the safety and efficacy of Epitomee® capsule versus the sham capsule control, alongside lifestyle ...